| Recent advances in the understanding of the pathophysiology and treatment of hyperprolactinemia. | |
| | |
MedLine Citation:
|
PMID: 8329652 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Hyperprolactinemia is frequently diagnosed in patients with infertility and menstrual cycle irregularities. Control of prolactin secretion is complex and involves inhibition by dopamine and possibly endothelins, as well as stimulation by serotoninergic and opioidergic pathways, gonadotropin-releasing hormone, and possibly galanin. Some patients with hyperprolactinemia have underlying functional disorders, but by using magnetic resonance imaging, a microprolactinoma can be found in most. Prolactin circulates in a low-bioactivity glycosylated and a nonglycosylated form, and an antibody-bound form is found in a few hyperprolactinemic patients who are relatively asymptomatic. The majority of patients, particularly those with macroprolactinomas, will benefit from treatment with bromocriptine. Available alternatives for intolerant patients include vaginal administration of bromocriptine and pergolide mesylate. Other compounds, monthly injectable and slow-release forms of bromocriptine, quinagolide and carbegoline, are not yet available in the United States. Withdrawal of treatment during pregnancy is still recommended, with a low risk of tumor enlargement, and the need for life-long treatment is now being reconsidered. |
| | |
Authors:
|
V Sarapura; W D Schlaff |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Current opinion in obstetrics & gynecology Volume: 5 ISSN: 1040-872X ISO Abbreviation: Curr. Opin. Obstet. Gynecol. Publication Date: 1993 Jun |
Date Detail:
|
Created Date: 1993-08-19 Completed Date: 1993-08-19 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 9007264 Medline TA: Curr Opin Obstet Gynecol Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 360-7 Citation Subset: IM |
Affiliation:
|
University of Colorado Health Sciences Center, Denver. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Bromocriptine
/
therapeutic use Female Humans Hyperprolactinemia / blood, diagnosis, drug therapy*, physiopathology* Magnetic Resonance Imaging Pergolide / therapeutic use Prolactin / biosynthesis, blood Receptors, Dopamine D2 / drug effects Signal Transduction Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Receptors, Dopamine D2; 25614-03-3/Bromocriptine; 66104-22-1/Pergolide; 9002-62-4/Prolactin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The potential roles of intraovarian peptides in normal and abnormal mechanisms of reproductive physi...
Next Document: New advances in the treatment of infertility in women with ovarian failure.